Stryker Corp
Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually.
Trading 38% above its estimated fair value of $206.96.
Current Price
$331.54
+0.65%GoodMoat Value
$206.96
37.6% overvaluedStryker Corp (SYK) Growth Projection
Stryker Corp — Growth Projection
SYK · NYSE · Healthcare
GoodMoat Target
“At nearly 40 times earnings, Stryker's valuation demands exceptional growth execution that leaves prudent investors with insufficient margin of safety despite solid fundamentals.”
— In the voice of Graham
What is the Growth Projection?
Project future earnings using analyst estimates and historical growth rates. Model 5-year earnings trajectories.
Key Metrics
Market Cap
$126.79B
P/E Ratio
39.06
Forward P/E
—
EPS
$8.40
PEG Ratio
0.72
Book Value
$58.63
Dividend Yield
1.01%
Profit Margin
12.92%
ROE
14.48%
Growth Projection — Data
Pre-loaded data for SYK:
Stryker Corp (SYK) Growth Projection
Project future earnings using analyst estimates and historical growth rates. Model 5-year earnings trajectories.
Stryker Corp is a Healthcare company in the Medical Devices industry, listed on NYSE. Current stock price: $331.54. Market capitalization: $126.79B. EPS: $8.40. P/E ratio: 39.06.
GoodMoat Fair Value target: $206.96. The stock appears 60.2% overvalued based on our blended model.
Use GoodMoat's Growth Projection alongside other valuation tools including DCF Calculator, Reverse DCF, Fair Value models, and Quality Score to build a comprehensive investment thesis for Stryker Corp (SYK). All tools are free to use and powered by real-time financial data.